Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
MAP kinase pathway regulation through dual specificity phosphatases	2/9	6.451389896168581E-4	0.11525381821065582	0	0	67.71088435374149	497.4071883260797	DUSP2;DUSP6
Alpha-M beta-2 integrin signaling	3/41	7.271534271965667E-4	0.11525381821065582	0	0	18.90551680405834	136.6183173401744	YES1;PLAU;CTGF
FGF signaling pathway	3/61	0.0023077831819962864	0.18037317202629163	0	0	12.373909430826755	75.12779361835821	PLAU;PTK2B;DUSP6
Cell adhesion molecules (CAMs)	4/133	0.002604939215151845	0.18037317202629163	0	0	7.481565513329552	44.51790296185119	HLA-DMB;CLDN8;CLDN23;NRXN3
Telomeres, telomerase, cellular aging, and immortality	2/19	0.0029800022502311685	0.18037317202629163	0	0	27.866946778711483	162.06945917517382	TEP1;MYC
AP-1 transcription factor network	3/70	0.003414003256018138	0.18037317202629163	0	0	10.706887250494516	60.813724484876275	PLAU;MYC;NFATC3
Tight junction interactions	2/30	0.007352053041878027	0.2441789980780126	0	0	16.90986394557823	83.07436833271562	CLDN8;CLDN23
Alpha-V beta-3 integrin/OPN pathway	2/31	0.007837281084236711	0.2441789980780126	0	0	16.325944170771756	79.16227161319938	PLAU;PTK2B
Alpha-synuclein signaling	2/32	0.008336574343939954	0.2441789980780126	0	0	15.780952380952382	75.54504286216243	YES1;PTK2B
Interleukin-7 signaling pathway	2/35	0.009917579220528824	0.2441789980780126	0	0	14.344155844155845	66.17599439349425	MYC;PTK2B
Interleukin-2 signaling pathway	9/847	0.010504484427924319	0.2441789980780126	0	0	2.660694913678207	12.122001039566456	YES1;PLAU;MYC;TIMP2;NRXN3;NFATC3;NRL;PTK2B;DUSP6
FRA pathway	2/37	0.011039601287524271	0.2441789980780126	0	0	13.52312925170068	60.938822348351906	PLAU;NFATC3
FOXM1 transcription factor network	2/41	0.01344245462757058	0.2441789980780126	0	0	12.133699633699633	52.28820471678212	MYC;NFATC3
Leukocyte transendothelial migration	3/117	0.014045104230061459	0.2441789980780126	0	0	6.2777425491439445	26.777594060429596	CLDN8;CLDN23;PTK2B
Wnt interactions in lipid metabolism and immune response	2/45	0.016050617607820547	0.2441789980780126	0	0	11.002768549280177	45.46352711662799	MYC;DUSP6
Cell-cell communication	3/129	0.018192270005093897	0.2441789980780126	0	0	5.676419965576592	22.74404394729898	CLDN8;CLDN23;PTK2B
Lipid and lipoprotein metabolism	6/489	0.018831867335496293	0.2441789980780126	0	0	3.0172360248447205	11.98507933951994	CYP27B1;SPTLC2;AGPS;ME1;GPCPD1;CTGF
Tight junction	3/133	0.01971009432441295	0.2441789980780126	0	0	5.50064874884152	21.59898144020572	YES1;CLDN8;CLDN23
Phenylalanine, tyrosine and tryptophan biosynthesis	1/5	0.0213178505521487	0.2441789980780126	0	0	58.55882352941177	225.34667975778618	GOT2
Ion channel and phorbal esters signaling pathway	1/5	0.0213178505521487	0.2441789980780126	0	0	58.55882352941177	225.34667975778618	PTK2B
Nifedipine activity	1/5	0.0213178505521487	0.2441789980780126	0	0	58.55882352941177	225.34667975778618	PTK2B
JNK/MAPK pathway	2/53	0.021852861604271988	0.2441789980780126	0	0	9.27310924369748	35.45502287445614	NFATC3;DUSP6
Thrombin signaling through protease-activated receptors	2/53	0.021852861604271988	0.2441789980780126	0	0	9.27310924369748	35.45502287445614	GNA14;PTK2B
Generic transcription pathway	5/377	0.023302147819362292	0.2441789980780126	0	0	3.242731979291119	12.190109645852997	MYC;ZSCAN32;ZNF514;CTGF;ZNF211
Thromboxane A2 receptor signaling	2/56	0.024220733969424094	0.2441789980780126	0	0	8.756613756613756	32.579386361435965	GNA14;YES1
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha	2/57	0.02503241519578498	0.2441789980780126	0	0	8.596969696969698	31.702045204893388	MYC;ME1
Cytochrome P450 metabolism of vitamins	1/6	0.025527220063161046	0.2441789980780126	0	0	46.84470588235294	171.82684693856828	CYP27B1
ER quality control compartment (ERQC)	1/6	0.025527220063161046	0.2441789980780126	0	0	46.84470588235294	171.82684693856828	EDEM2
Fas signaling pathway in hepatocytes	1/6	0.025527220063161046	0.2441789980780126	0	0	46.84470588235294	171.82684693856828	YES1
EGFR1 pathway	3/152	0.027850012759727854	0.2441789980780126	0	0	4.794614700412388	17.169140564373766	PLAU;MYC;DUSP6
Interleukin-4 regulation of apoptosis	4/267	0.028134047170069707	0.2441789980780126	0	0	3.6448112770101084	13.014800233286508	EGLN3;MYC;TIMP2;DUSP6
SLC26 family multifunctional anion exchangers	1/7	0.029718695945433443	0.2441789980780126	0	0	39.03529411764706	137.24727196053433	SLC26A2
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1/7	0.029718695945433443	0.2441789980780126	0	0	39.03529411764706	137.24727196053433	SLC29A3
Vitamin D (calciferol) metabolism	1/7	0.029718695945433443	0.2441789980780126	0	0	39.03529411764706	137.24727196053433	CYP27B1
MAPK cascade role in angiogenesis	2/64	0.031016626738509495	0.2441789980780126	0	0	7.623655913978495	26.478724700644403	TIMP2;PTK2B
Endothelins	2/64	0.031016626738509495	0.2441789980780126	0	0	7.623655913978495	26.478724700644403	GNA14;PTK2B
LPA receptor mediated events	2/65	0.031913456894228094	0.2441789980780126	0	0	7.5022675736961455	25.843267512966868	GNA14;PTK2B
ERK1/ERK2 MAPK pathway	2/65	0.031913456894228094	0.2441789980780126	0	0	7.5022675736961455	25.843267512966868	MYC;DUSP6
Hydrolysis of lysophosphatidylcholine (LPC)	1/8	0.03389235304552857	0.2441789980780126	0	0	33.457142857142856	113.23790361856584	GPCPD1
Insulin secretion regulation by fatty acids bound to GPR40 (FFAR1)	1/8	0.03389235304552857	0.2441789980780126	0	0	33.457142857142856	113.23790361856584	GNA14
Binding of RNA by insulin-like growth factor 2 mRNA binding proteins (IGF2BPs/IMPs/VICKZs)	1/8	0.03389235304552857	0.2441789980780126	0	0	33.457142857142856	113.23790361856584	MYC
Shuttle for transfer of acetyl groups from mitochondria to the cytosol	1/8	0.03389235304552857	0.2441789980780126	0	0	33.457142857142856	113.23790361856584	ME1
Dissolution of fibrin clot	1/8	0.03389235304552857	0.2441789980780126	0	0	33.457142857142856	113.23790361856584	PLAU
Vitamin D biosynthesis	1/8	0.03389235304552857	0.2441789980780126	0	0	33.457142857142856	113.23790361856584	CYP27B1
Inhibition of matrix metalloproteinases	1/9	0.03804826600753207	0.26220218096494924	0	0	29.273529411764706	95.69223347722578	TIMP2
Calcium-activated potassium channels	1/9	0.03804826600753207	0.26220218096494924	0	0	29.273529411764706	95.69223347722578	KCNMA1
E2F transcription factor network	2/74	0.040430719502884356	0.272692299625837	0	0	6.561507936507937	21.050402728648404	PLAU;MYC
Insulin secretion regulation by acetylcholine	1/10	0.0421865092184754	0.2786067379636813	0	0	26.019607843137255	82.36909635390154	GNA14
Oncostatin M	4/311	0.04517179533294532	0.2832003173858027	0	0	3.115436561531739	9.649386780407935	PLAU;MYC;TIMP2;CTGF
Telomerase protein component gene hTERT transcriptional regulation	1/11	0.04630715680061324	0.2832003173858027	0	0	23.416470588235295	71.94614007723759	MYC
Osteopontin signaling	1/11	0.04630715680061324	0.2832003173858027	0	0	23.416470588235295	71.94614007723759	PLAU
ATM-dependent DNA damage response	2/82	0.04863524067206779	0.2832003173858027	0	0	5.90297619047619	17.847098910209784	PLAU;MYC
Platelet endothelial cell adhesion molecule 1 (PECAM1) interactions	1/12	0.05041028257884421	0.2832003173858027	0	0	21.28663101604278	63.595089599609956	YES1
Alanine and aspartate metabolism	1/12	0.05041028257884421	0.2832003173858027	0	0	21.28663101604278	63.595089599609956	GOT2
ERK inactivation	1/12	0.05041028257884421	0.2832003173858027	0	0	21.28663101604278	63.595089599609956	DUSP6
Cell junction organization	2/84	0.05077354142722034	0.2832003173858027	0	0	5.758420441347271	17.16228052835959	CLDN8;CLDN23
Ghrelin-mediated regulation of food intake and energy homeostasis	1/13	0.05449596012786739	0.2832003173858027	0	0	19.511764705882353	56.77199069596926	IGFBP5
Signal regulatory protein (SIRP) family interactions	1/13	0.05449596012786739	0.2832003173858027	0	0	19.511764705882353	56.77199069596926	PTK2B
Sulfur metabolism	1/13	0.05449596012786739	0.2832003173858027	0	0	19.511764705882353	56.77199069596926	PAPSS2
Cytosolic sulfonation of small molecules	1/13	0.05449596012786739	0.2832003173858027	0	0	19.511764705882353	56.77199069596926	PAPSS2
N-glycan trimming in the ER and calnexin/calreticulin cycle	1/13	0.05449596012786739	0.2832003173858027	0	0	19.511764705882353	56.77199069596926	EDEM2
Platelet amyloid precursor protein pathway	1/14	0.05856426270354889	0.2938392879193283	0	0	18.00995475113122	51.10559906499446	PLAU
Calcium signaling by HBx of hepatitis B virus	1/15	0.06261526327259834	0.2938392879193283	0	0	16.722689075630253	46.33432734971711	PTK2B
Fibrinolysis pathway	1/15	0.06261526327259834	0.2938392879193283	0	0	16.722689075630253	46.33432734971711	PLAU
Transport of inorganic cations/anions and amino acids/oligopeptides	2/95	0.06311230005452048	0.2938392879193283	0	0	5.074500768049155	14.0200316665264	SLC26A2;SLC1A4
TSH regulation of gene expression	2/97	0.06545517817555309	0.2938392879193283	0	0	4.967167919799499	13.542435321821051	DUSP2;MYC
Wnt signaling pathway and pluripotency	2/98	0.06663750286280484	0.2938392879193283	0	0	4.915178571428571	13.312700968810276	PLAU;MYC
Amino acid biosynthesis and interconversion (transamination)	1/16	0.06664903451940749	0.2938392879193283	0	0	15.607058823529412	42.26882712102443	GOT2
KIT signaling regulation	1/16	0.06664903451940749	0.2938392879193283	0	0	15.607058823529412	42.26882712102443	YES1
Phenylalanine metabolism	1/17	0.0706656488135395	0.2938392879193283	0	0	14.630882352941176	38.768849097220134	GOT2
Insulin-like growth factor (IGF) activity regulation by insulin-like growth factor binding proteins (IGFBPs)	1/17	0.0706656488135395	0.2938392879193283	0	0	14.630882352941176	38.768849097220134	IGFBP5
Integrin beta-5 pathway	1/17	0.0706656488135395	0.2938392879193283	0	0	14.630882352941176	38.768849097220134	PLAU
Cadmium-induced DNA biosynthesis and proliferation in macrophages	1/17	0.0706656488135395	0.2938392879193283	0	0	14.630882352941176	38.768849097220134	MYC
Sulfation biotransformation reaction	1/17	0.0706656488135395	0.2938392879193283	0	0	14.630882352941176	38.768849097220134	PAPSS2
Synaptic proteins at the synaptic junction	1/17	0.0706656488135395	0.2938392879193283	0	0	14.630882352941176	38.768849097220134	NRXN3
Pertussis toxin-insensitive CCR5 signaling in macrophage	1/18	0.07466517827093744	0.2938392879193283	0	0	13.76955017301038	35.728422579909434	PTK2B
CBL signaling regulation	1/18	0.07466517827093744	0.2938392879193283	0	0	13.76955017301038	35.728422579909434	YES1
Nicotinic acetylcholine receptor role in the regulation of apoptosis	1/18	0.07466517827093744	0.2938392879193283	0	0	13.76955017301038	35.728422579909434	PTK2B
Wnt signaling pathway	3/231	0.07760020199677506	0.2938392879193283	0	0	3.1207989854153455	7.977340330817465	PLAU;MYC;NFATC3
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	1/19	0.07864769465120389	0.2938392879193283	0	0	13.003921568627451	33.06607217254294	EGLN3
Calcineurin in effects in keratinocyte differentiation	1/19	0.07864769465120389	0.2938392879193283	0	0	13.003921568627451	33.06607217254294	NFATC3
Class C GPCRs (metabotropic glutamate and pheromone receptors)	1/19	0.07864769465120389	0.2938392879193283	0	0	13.003921568627451	33.06607217254294	GPRC5C
TP53 network	1/19	0.07864769465120389	0.2938392879193283	0	0	13.003921568627451	33.06607217254294	MYC
Signaling by interleukins	2/109	0.08009710463755176	0.2938392879193283	0	0	4.4074321317311975	11.12663105088759	YES1;PTK2B
Peroxisomal lipid metabolism	1/20	0.08261326946777713	0.2938392879193283	0	0	12.318885448916408	30.718187529247054	AGPS
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha)	2/112	0.08390411125488344	0.2938392879193283	0	0	4.286580086580087	10.622491230942934	ME1;CTGF
Fas signaling pathway	2/115	0.08776560317489009	0.2938392879193283	0	0	4.1721449641803625	10.151185910579056	NFATC3;FAIM2
CXCR4 signaling pathway	2/116	0.0890645301084317	0.2938392879193283	0	0	4.135338345864661	10.000877917432021	YES1;PTK2B
CTLA4 inhibitory signaling	1/22	0.0904938789441273	0.2938392879193283	0	0	11.14453781512605	26.774451939878727	YES1
Prolactin regulation of apoptosis	2/118	0.09167959186687909	0.2938392879193283	0	0	4.063628899835797	9.70986033421283	EGLN3;DUSP6
SLC-mediated transmembrane transport	3/251	0.09389558563661556	0.2938392879193283	0	0	2.866206762534007	6.780218191937916	SLC26A2;SLC1A4;SLC29A3
Angiogenesis	1/23	0.0944090551290999	0.2938392879193283	0	0	10.637433155080213	25.105600520866265	TIMP2
Blood clotting cascade	1/23	0.0944090551290999	0.2938392879193283	0	0	10.637433155080213	25.105600520866265	PLAU
Interleukin-11 pathway	1/23	0.0944090551290999	0.2938392879193283	0	0	10.637433155080213	25.105600520866265	DUSP6
TGF-beta regulation of extracellular matrix	5/565	0.09627194384448187	0.2938392879193283	0	0	2.133377425044092	4.9933370002205475	MYC;ME1;ARHGEF3;SLC1A4;CTGF
Ras-independent pathway in NK cell-mediated cytotoxicity	1/24	0.09830757280729437	0.2938392879193283	0	0	10.174424552429668	23.601146819428006	PTK2B
Inhibition of cellular proliferation by Gleevec	1/24	0.09830757280729437	0.2938392879193283	0	0	10.174424552429668	23.601146819428006	MYC
SREBP signaling	1/24	0.09830757280729437	0.2938392879193283	0	0	10.174424552429668	23.601146819428006	INSIG2
Triacylglyceride biosynthesis	1/24	0.09830757280729437	0.2938392879193283	0	0	10.174424552429668	23.601146819428006	AGPS
Tumor suppressor Arf inhibits ribosomal biogenesis	1/24	0.09830757280729437	0.2938392879193283	0	0	10.174424552429668	23.601146819428006	MYC
C-Myc pathway	1/25	0.10218950202672386	0.2938392879193283	0	0	9.75	22.23903168224061	MYC
Cellular response to hypoxia	1/25	0.10218950202672386	0.2938392879193283	0	0	9.75	22.23903168224061	EGLN3
Inhibition of activated T cell apoptosis by neuropeptides VIP and PACAP	1/26	0.10605491252536185	0.2938392879193283	0	0	9.359529411764706	21.000895961244385	MYC
Selenoamino acid metabolism	1/26	0.10605491252536185	0.2938392879193283	0	0	9.359529411764706	21.000895961244385	PAPSS2
Interleukin-9 regulation of target genes	1/26	0.10605491252536185	0.2938392879193283	0	0	9.359529411764706	21.000895961244385	MYC
Steroid biosynthesis	1/26	0.10605491252536185	0.2938392879193283	0	0	9.359529411764706	21.000895961244385	CYP27B1
YAP1- and WWTR1 (TAZ)-stimulated gene expression	1/26	0.10605491252536185	0.2938392879193283	0	0	9.359529411764706	21.000895961244385	CTGF
Fibroblast growth factor 1	1/26	0.10605491252536185	0.2938392879193283	0	0	9.359529411764706	21.000895961244385	PLAU
PDGFB signaling pathway	2/129	0.10644898188957604	0.2938392879193283	0	0	3.709598800149981	8.309833143000272	YES1;MYC
Proteins and DNA sequences in cardicac structures	1/27	0.1099038737594078	0.2938392879193283	0	0	8.999095022624434	19.871344206358376	NFATC3
CTCF pathway	1/27	0.1099038737594078	0.2938392879193283	0	0	8.999095022624434	19.871344206358376	MYC
Nitric oxide stimulation of guanylate cyclase	1/28	0.11373645491494558	0.2938392879193283	0	0	8.665359477124182	18.837376322734553	KCNMA1
Transmembrane transport of small molecules	4/432	0.11562475556663439	0.2938392879193283	0	0	2.2208798723501255	4.791337778898583	SLC26A2;SLC1A4;ABCC11;SLC29A3
Association of TriC/CCT with target proteins during biosynthesis	1/29	0.117552724870697	0.2938392879193283	0	0	8.35546218487395	17.887944321802927	FBXW5
S1P/S1P3 pathway	1/29	0.117552724870697	0.2938392879193283	0	0	8.35546218487395	17.887944321802927	GNA14
Integrin beta-2 pathway	1/29	0.117552724870697	0.2938392879193283	0	0	8.35546218487395	17.887944321802927	PLAU
T cell receptor calcium pathway	1/29	0.117552724870697	0.2938392879193283	0	0	8.35546218487395	17.887944321802927	NFATC3
Matrix metalloproteinases	1/29	0.117552724870697	0.2938392879193283	0	0	8.35546218487395	17.887944321802927	TIMP2
Thyroid cancer	1/29	0.117552724870697	0.2938392879193283	0	0	8.35546218487395	17.887944321802927	MYC
Diabetes pathways	2/137	0.11756506839470834	0.2938392879193283	0	0	3.4883597883597885	7.467752699680994	IGFBP5;MYC
Natural killer cell-mediated cytotoxicity	2/137	0.11756506839470834	0.2938392879193283	0	0	3.4883597883597885	7.467752699680994	NFATC3;PTK2B
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	3/280	0.11977213951358853	0.2938392879193283	0	0	2.5623504849723804	5.437728412390606	YES1;PTK2B;OASL
Biological oxidations	2/139	0.12038882474315822	0.2938392879193283	0	0	3.437087243656587	7.276411886089979	CYP27B1;PAPSS2
Activation of matrix metalloproteinases	1/30	0.12135275220631468	0.2938392879193283	0	0	8.066937119675456	17.0136033150249	TIMP2
Asthma	1/30	0.12135275220631468	0.2938392879193283	0	0	8.066937119675456	17.0136033150249	HLA-DMB
Interleukin-2/STAT5 pathway	1/30	0.12135275220631468	0.2938392879193283	0	0	8.066937119675456	17.0136033150249	MYC
Signaling pathway from G-protein families	1/30	0.12135275220631468	0.2938392879193283	0	0	8.066937119675456	17.0136033150249	NFATC3
Nuclear events mediated by MAP kinases	1/30	0.12135275220631468	0.2938392879193283	0	0	8.066937119675456	17.0136033150249	DUSP6
p38-alpha and p38-beta regulation	1/30	0.12135275220631468	0.2938392879193283	0	0	8.066937119675456	17.0136033150249	YES1
Gluconeogenesis	1/31	0.12513660526532908	0.2938392879193283	0	0	7.79764705882353	16.206234277302418	GOT2
Amino acid transport across the plasma membrane	1/31	0.12513660526532908	0.2938392879193283	0	0	7.79764705882353	16.206234277302418	SLC1A4
Signal amplification	1/31	0.12513660526532908	0.2938392879193283	0	0	7.79764705882353	16.206234277302418	GNA14
CD28 co-stimulation	1/31	0.12513660526532908	0.2938392879193283	0	0	7.79764705882353	16.206234277302418	YES1
CD40/CD40L signaling	1/31	0.12513660526532908	0.2938392879193283	0	0	7.79764705882353	16.206234277302418	MYC
Transport of vitamins, nucleosides, and related molecules	1/31	0.12513660526532908	0.2938392879193283	0	0	7.79764705882353	16.206234277302418	SLC29A3
Interleukin-5 regulation of apoptosis	2/144	0.12752104844925152	0.29397611223673153	0	0	3.3152246814218644	6.827618512179875	YES1;DUSP6
Alanine, aspartate and glutamate metabolism	1/32	0.12890435205333023	0.29397611223673153	0	0	7.54573055028463	15.458822023817966	GOT2
Sphingolipid de novo biosynthesis	1/32	0.12890435205333023	0.29397611223673153	0	0	7.54573055028463	15.458822023817966	SPTLC2
Netrin-mediated signaling events	1/32	0.12890435205333023	0.29397611223673153	0	0	7.54573055028463	15.458822023817966	YES1
HIF-2-alpha transcription factor network	1/34	0.1363917975983422	0.3001039663365875	0	0	7.0877005347593585	14.12028477327799	EGLN3
Cysteine and methionine metabolism	1/34	0.1363917975983422	0.3001039663365875	0	0	7.0877005347593585	14.12028477327799	GOT2
EGF receptor transactivation by GPCRs in cardiac hypertrophy	1/34	0.1363917975983422	0.3001039663365875	0	0	7.0877005347593585	14.12028477327799	MYC
Ephrin receptor A forward pathway	1/34	0.1363917975983422	0.3001039663365875	0	0	7.0877005347593585	14.12028477327799	YES1
Nuclear receptors in lipid metabolism and toxicity	1/34	0.1363917975983422	0.3001039663365875	0	0	7.0877005347593585	14.12028477327799	CYP27B1
Arf6 signal transduction regulation	1/35	0.14011163097102505	0.3001039663365875	0	0	6.8788927335640135	13.519196644704605	GNA14
Interleukin-2/PI3K pathway	1/35	0.14011163097102505	0.3001039663365875	0	0	6.8788927335640135	13.519196644704605	MYC
Ether lipid metabolism	1/35	0.14011163097102505	0.3001039663365875	0	0	6.8788927335640135	13.519196644704605	AGPS
fMLP induced chemokine gene expression in HMC-1 cells	1/35	0.14011163097102505	0.3001039663365875	0	0	6.8788927335640135	13.519196644704605	NFATC3
Hemostasis pathway	4/468	0.14258016922992955	0.3033417023213938	0	0	2.044785534062237	3.98293723319125	GNA14;YES1;PLAU;KCNMA1
Steroid hormone, vitamin A, and vitamin D metabolism	1/36	0.14381562741602863	0.3039303592725405	0	0	6.6820168067226895	12.957921780117758	CYP27B1
Allograft rejection	1/37	0.1475038535361489	0.30966040775469666	0	0	6.496078431372549	12.432850862154837	HLA-DMB
Signaling of hepatocyte growth factor receptor	1/38	0.1511763756964482	0.315282309840619	0	0	6.320190779014308	11.94078746066896	PTK2B
MAPK signaling pathway	3/314	0.15303317127689267	0.31706872741682995	0	0	2.278270638825398	4.276543126958896	DUSP2;MYC;DUSP6
Angiotensin II-mediated activation of JNK pathway via Pyk2-dependent signaling	1/39	0.1548332599823739	0.31871521697670474	0	0	6.1535603715170275	11.47889141140809	PTK2B
Plasma membrane estrogen receptor signaling	1/41	0.1621003778502616	0.3211613736158308	0	0	5.845294117647059	10.635743648833243	GNA14
Graft-versus-host disease	1/41	0.1621003778502616	0.3211613736158308	0	0	5.845294117647059	10.635743648833243	HLA-DMB
Bioactive peptide-induced signaling pathway	1/41	0.1621003778502616	0.3211613736158308	0	0	5.845294117647059	10.635743648833243	PTK2B
Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer	1/41	0.1621003778502616	0.3211613736158308	0	0	5.845294117647059	10.635743648833243	MYC
Tyrosine metabolism	1/41	0.1621003778502616	0.3211613736158308	0	0	5.845294117647059	10.635743648833243	GOT2
Fc epsilon receptor I signaling in mast cells	1/41	0.1621003778502616	0.3211613736158308	0	0	5.845294117647059	10.635743648833243	NFATC3
Bladder cancer	1/42	0.16571074221421955	0.324261143715479	0	0	5.702439024390244	10.250199880384558	MYC
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling	1/42	0.16571074221421955	0.324261143715479	0	0	5.702439024390244	10.250199880384558	PLAU
Beta-3 integrin cell surface interactions	1/43	0.16930573029517199	0.3272555884363995	0	0	5.5663865546218485	9.886176072320994	PLAU
Type 1 diabetes mellitus	1/43	0.16930573029517199	0.3272555884363995	0	0	5.5663865546218485	9.886176072320994	HLA-DMB
Fatty acid, triacylglycerol, and ketone body metabolism	2/173	0.17059885660194746	0.32775659116858996	0	0	2.7489557226399333	4.861364209732221	ME1;CTGF
Heart development	1/44	0.17288540678205494	0.3301486382524784	0	0	5.436662106703146	9.54202860693275	NFATC3
Interleukin-3, interleukin-5, and GM-CSF signaling	1/45	0.17644983614692364	0.33493771292559754	0	0	5.31283422459893	9.216272653459013	YES1
Calcium signaling pathway	2/178	0.17826194276897306	0.3363007371965862	0	0	2.670183982683983	4.604735540637937	GNA14;PTK2B
RhoA activity regulation	1/46	0.17999908252900587	0.3363007371965862	0	0	5.1945098039215685	8.907563723274029	ARHGEF3
ABC transporters	1/47	0.1835332098896196	0.3363007371965862	0	0	5.081329923273657	8.61468170774335	ABCC11
Regulation of NFAT transcription factors	1/47	0.1835332098896196	0.3363007371965862	0	0	5.081329923273657	8.61468170774335	NFATC3
Regulation of transcription by NOTCH1 intracellular domain	1/47	0.1835332098896196	0.3363007371965862	0	0	5.081329923273657	8.61468170774335	MYC
LKB1 signaling events	1/47	0.1835332098896196	0.3363007371965862	0	0	5.081329923273657	8.61468170774335	MYC
Presenilin action in Notch and Wnt signaling	1/48	0.1870522818483187	0.3374657356727317	0	0	4.9729662077597	8.336517035216884	MYC
Intestinal immune network for IgA production	1/48	0.1870522818483187	0.3374657356727317	0	0	4.9729662077597	8.336517035216884	HLA-DMB
TGF-beta signaling pathway	2/185	0.18907862571172304	0.3374657356727317	0	0	2.567135050741608	4.275800479786785	MYC;CTGF
Amino acid and oligopeptide SLC transporters	1/49	0.19055636178365606	0.3374657356727317	0	0	4.8691176470588236	8.072058613293224	SLC1A4
Interleukin-5 signaling pathway	1/49	0.19055636178365606	0.3374657356727317	0	0	4.8691176470588236	8.072058613293224	MYC
Ceramide signaling pathway	1/49	0.19055636178365606	0.3374657356727317	0	0	4.8691176470588236	8.072058613293224	MYC
Pyruvate metabolism	1/52	0.20097927946738411	0.3462523456041346	0	0	4.582006920415225	7.3520750737676215	ME1
Autoimmune thyroid disease	1/52	0.20097927946738411	0.3462523456041346	0	0	4.582006920415225	7.3520750737676215	HLA-DMB
Interleukin-2 receptor beta chain in T cell activation	1/52	0.20097927946738411	0.3462523456041346	0	0	4.582006920415225	7.3520750737676215	MYC
Signaling events mediated by PTP1B	1/52	0.20097927946738411	0.3462523456041346	0	0	4.582006920415225	7.3520750737676215	YES1
Endometrial cancer	1/52	0.20097927946738411	0.3462523456041346	0	0	4.582006920415225	7.3520750737676215	MYC
Protein folding	1/53	0.2044240199319846	0.3502833206402115	0	0	4.493665158371041	7.133958175164451	FBXW5
RANKL signaling pathway	1/54	0.20785408138648875	0.3523515711204114	0	0	4.40865704772475	6.92564302052444	PAPSS2
Arginine and proline metabolism	1/54	0.20785408138648875	0.3523515711204114	0	0	4.40865704772475	6.92564302052444	GOT2
Calcineurin-dependent NFAT signaling role in lymphocytes	1/55	0.2112695256357926	0.3562363809922673	0	0	4.326797385620915	6.726528295665297	NFATC3
Acute myeloid leukemia	1/57	0.21805680846438996	0.3657354935619662	0	0	4.171848739495799	6.353724215387732	MYC
Phospholipid metabolism	2/205	0.22042550506656117	0.36776255318999945	0	0	2.3118695754163734	3.4959987377397814	SPTLC2;GPCPD1
ATF2 transcription factor network	1/59	0.22478635787963117	0.37046470509209717	0	0	4.027586206896552	6.011594699734063	PLAU
RNA degradation	1/59	0.22478635787963117	0.37046470509209717	0	0	4.027586206896552	6.011594699734063	TTC37
RAGE pathway	1/60	0.22812963437579506	0.37046470509209717	0	0	3.9591226321036888	5.850954699068187	CTGF
Ephrin receptor B forward pathway	1/60	0.22812963437579506	0.37046470509209717	0	0	3.9591226321036888	5.850954699068187	YES1
Antigen-activated B-cell receptor generation of second messengers	2/211	0.22992239559611918	0.37046470509209717	0	0	2.24481658692185	3.2999105473774852	MYC;NFATC3
Glucose metabolism	1/61	0.23145865919344172	0.37046470509209717	0	0	3.8929411764705883	5.696751040020639	GOT2
Androgen receptor proteolysis and transcription regulation	1/61	0.23145865919344172	0.37046470509209717	0	0	3.8929411764705883	5.696751040020639	PTK2B
Cytochrome P450 pathway	1/61	0.23145865919344172	0.37046470509209717	0	0	3.8929411764705883	5.696751040020639	CYP27B1
Signaling events mediated by focal adhesion kinase	1/62	0.23477349240113526	0.37046470509209717	0	0	3.828929604628737	5.548632425072559	YES1
Colorectal cancer	1/62	0.23477349240113526	0.37046470509209717	0	0	3.828929604628737	5.548632425072559	MYC
Interferon alpha/beta signaling	1/64	0.24136082280652457	0.37046470509209717	0	0	3.7070028011204483	5.269364635462472	OASL
Validated nuclear estrogen receptor alpha network	1/64	0.24136082280652457	0.37046470509209717	0	0	3.7070028011204483	5.269364635462472	MYC
Signaling by NGF	2/221	0.24580988549453303	0.37046470509209717	0	0	2.141226353555121	3.0045621066164303	ARHGEF3;DUSP6
HIF-1 transcriptional activity in hypoxia	1/66	0.24789210093701325	0.37046470509209717	0	0	3.592579185520362	5.010791867835437	EGLN3
Beta-1 integrin cell surface interactions	1/66	0.24789210093701325	0.37046470509209717	0	0	3.592579185520362	5.010791867835437	PLAU
Signaling by TGF-beta receptor complex	1/66	0.24789210093701325	0.37046470509209717	0	0	3.592579185520362	5.010791867835437	MYC
Thyroid-stimulating hormone signaling pathway	1/66	0.24789210093701325	0.37046470509209717	0	0	3.592579185520362	5.010791867835437	MYC
Endochondral ossification	1/66	0.24789210093701325	0.37046470509209717	0	0	3.592579185520362	5.010791867835437	PLAU
G alpha 13 pathway	1/67	0.25113686786289574	0.37046470509209717	0	0	3.537967914438503	4.888612632693461	ARHGEF3
G1 to S cell cycle control	1/67	0.25113686786289574	0.37046470509209717	0	0	3.537967914438503	4.888612632693461	MYC
Telomerase regulation	1/67	0.25113686786289574	0.37046470509209717	0	0	3.537967914438503	4.888612632693461	MYC
CD8/T cell receptor downstream pathway	1/68	0.2543677981624342	0.37046470509209717	0	0	3.4849868305531166	4.770856483616748	NFATC3
Metabolism	9/1615	0.2574318566678676	0.37046470509209717	0	0	1.3324384208568518	1.8081192411648284	CYP27B1;GNA14;SPTLC2;AGPS;GOT2;ME1;GPCPD1;PAPSS2;CTGF
Phase I of biological oxidations: functionalization of compounds	1/69	0.2575849502210434	0.37046470509209717	0	0	3.4335640138408303	4.657305832354093	CYP27B1
NFAT involvement in hypertrophy of the heart	1/69	0.2575849502210434	0.37046470509209717	0	0	3.4335640138408303	4.657305832354093	NFATC3
PPAR signaling pathway	1/69	0.2575849502210434	0.37046470509209717	0	0	3.4335640138408303	4.657305832354093	ME1
Renal cell carcinoma	1/70	0.260788382019869	0.37046470509209717	0	0	3.3836317135549874	4.547756661251317	EGLN3
CDC42 signaling events	1/70	0.260788382019869	0.37046470509209717	0	0	3.3836317135549874	4.547756661251317	YES1
Signaling events mediated by VEGFR1 and VEGFR2	1/70	0.260788382019869	0.37046470509209717	0	0	3.3836317135549874	4.547756661251317	PTK2B
Complement and coagulation cascades	1/70	0.260788382019869	0.37046470509209717	0	0	3.3836317135549874	4.547756661251317	PLAU
MicroRNA regulation of DNA damage response	1/70	0.260788382019869	0.37046470509209717	0	0	3.3836317135549874	4.547756661251317	MYC
Phase II of biological oxidations: conjugation	1/71	0.2639781514229198	0.37046470509209717	0	0	3.335126050420168	4.442017496799639	PAPSS2
Interleukin-6 signaling pathway	1/71	0.2639781514229198	0.37046470509209717	0	0	3.335126050420168	4.442017496799639	MYC
Viral myocarditis	1/71	0.2639781514229198	0.37046470509209717	0	0	3.335126050420168	4.442017496799639	HLA-DMB
Leishmaniasis	1/72	0.2671543160230924	0.37046470509209717	0	0	3.287986743993372	4.3399084793012666	HLA-DMB
Sphingolipid metabolism	1/72	0.2671543160230924	0.37046470509209717	0	0	3.287986743993372	4.3399084793012666	SPTLC2
Costimulation by the CD28 family	1/72	0.2671543160230924	0.37046470509209717	0	0	3.287986743993372	4.3399084793012666	YES1
Cyclin A-Cdk2-associated events at S phase entry	1/72	0.2671543160230924	0.37046470509209717	0	0	3.287986743993372	4.3399084793012666	MYC
Signaling by NOTCH1	1/73	0.27031693312159105	0.37046470509209717	0	0	3.242156862745098	4.241260511650994	MYC
Chronic myeloid leukemia	1/73	0.27031693312159105	0.37046470509209717	0	0	3.242156862745098	4.241260511650994	MYC
Myc repressed pathway	1/73	0.27031693312159105	0.37046470509209717	0	0	3.242156862745098	4.241260511650994	MYC
Adherens junction cell adhesion	1/74	0.2734660599102547	0.37046470509209717	0	0	3.1975825946817085	4.1459144787075015	YES1
Integrins in angiogenesis	1/74	0.2734660599102547	0.37046470509209717	0	0	3.1975825946817085	4.1459144787075015	PTK2B
Wnt/calcium/cyclic GMP pathway	1/74	0.2734660599102547	0.37046470509209717	0	0	3.1975825946817085	4.1459144787075015	NFATC3
Prolactin activation of MAPK signaling	1/75	0.2766017531435907	0.37153710062084006	0	0	3.1542130365659777	4.053720538658391	MYC
Glycolysis and gluconeogenesis	1/75	0.2766017531435907	0.37153710062084006	0	0	3.1542130365659777	4.053720538658391	GOT2
VEGF signaling pathway	1/76	0.2797240695996395	0.3741456964687162	0	0	3.112	3.9645374645280653	NFATC3
G alpha (12/13) signaling events	1/77	0.2828330655678514	0.37671462934877686	0	0	3.0708978328173373	3.878232050839515	ARHGEF3
Peroxisome	1/78	0.285928797233274	0.3776642863456161	0	0	3.030863254392666	3.7946785586949976	AGPS
Signaling by SCF-KIT	1/78	0.285928797233274	0.3776642863456161	0	0	3.030863254392666	3.7946785586949976	YES1
p73 transcription factor network	1/79	0.28901132054107104	0.3801518199648113	0	0	2.9918552036199095	3.7137582110670744	MYC
Nuclear beta-catenin signaling and target gene transcription regulation	1/80	0.29208069113529117	0.3826015664871376	0	0	2.9538346984363364	3.6353587272888825	MYC
Antigen processing and presentation	1/81	0.2951369645576914	0.3826847049662462	0	0	2.916764705882353	3.559373891413559	HLA-DMB
MAP kinase signaling pathway	1/81	0.2951369645576914	0.3826847049662462	0	0	2.916764705882353	3.559373891413559	MYC
Platelet homeostasis	1/82	0.2981801959831634	0.3826847049662462	0	0	2.8806100217864925	3.485703158576593	KCNMA1
Regular glucocorticoid receptor pathway	1/82	0.2981801959831634	0.3826847049662462	0	0	2.8806100217864925	3.485703158576593	PBX1
SMAD2/3 nuclear pathway	1/82	0.2981801959831634	0.3826847049662462	0	0	2.8806100217864925	3.485703158576593	MYC
T cell signal transduction	1/83	0.30121044042613215	0.3849510013834438	0	0	2.8453371592539454	3.414251286864614	NFATC3
Small cell lung cancer	1/84	0.30422775267512436	0.3849510013834438	0	0	2.810914245216159	3.34492799962935	MYC
Asparagine N-linked glycosylation	1/85	0.3072321872240103	0.3849510013834438	0	0	2.777310924369748	3.2776476730175657	EDEM2
C-Myb transcription factor network	1/85	0.3072321872240103	0.3849510013834438	0	0	2.777310924369748	3.2776476730175657	MYC
TGF-beta regulation of skeletal system development	1/85	0.3072321872240103	0.3849510013834438	0	0	2.777310924369748	3.2776476730175657	MYC
Myc active pathway	1/85	0.3072321872240103	0.3849510013834438	0	0	2.777310924369748	3.2776476730175657	MYC
BDNF signaling pathway	2/261	0.3095024254318626	0.3856507612191833	0	0	1.8068578782864497	2.1190636771143656	IGFBP5;MYC
Glycerophospholipid biosynthesis	1/86	0.3102237984570717	0.3856507612191833	0	0	2.744498269896194	3.212329044289917	GPCPD1
FSH regulation of apoptosis	2/263	0.3126723294651043	0.3871762829704612	0	0	1.7928297755883962	2.084343014152612	IGFBP5;PAPSS2
Salivary secretion	1/89	0.3191222318731329	0.39362547666841685	0	0	2.6505347593582886	3.02739064758815	KCNMA1
Thymic stromal lymphopoietin (TSLP) pathway	1/90	0.3220630883751708	0.39571317447646953	0	0	2.6206212822207533	2.969184421732711	MYC
Neural crest differentiation	1/91	0.32499138972030267	0.39776938432948244	0	0	2.591372549019608	2.9125902540604933	MYC
Extracellular matrix organization	1/93	0.33081053867204613	0.40333438753476397	0	0	2.534782608695652	2.8040004962252554	TIMP2
Cell surface interactions at the vascular wall	1/94	0.33370149159207996	0.403753331430112	0	0	2.5074003795066413	2.7518930372832235	YES1
ERBB signaling pathway	1/94	0.33370149159207996	0.403753331430112	0	0	2.5074003795066413	2.7518930372832235	MYC
G-protein signaling pathways	1/95	0.3365800999191507	0.4056878010432349	0	0	2.4806007509386734	2.7011735863649435	GNA14
Interferon-gamma signaling pathway	1/97	0.34230049098939735	0.4110199077410566	0	0	2.4286764705882353	2.6037021954467265	OASL
Potassium channels	1/99	0.3479721261088416	0.41468858637783	0	0	2.378871548619448	2.511215071130418	KCNMA1
Senescence and autophagy	1/99	0.3479721261088416	0.41468858637783	0	0	2.378871548619448	2.511215071130418	IGFBP5
Pancreatic secretion	1/101	0.35359541597416516	0.4182453241186953	0	0	2.331058823529412	2.4233732103374237	KCNMA1
GnRH signaling pathway	1/101	0.35359541597416516	0.4182453241186953	0	0	2.331058823529412	2.4233732103374237	PTK2B
Signaling by ERBB2	1/102	0.35638905886629263	0.4199826455784935	0	0	2.3078625509609783	2.381096298287925	YES1
MHC class II antigen presentation	1/103	0.3591707678710129	0.4216930867226336	0	0	2.285121107266436	2.339866501030391	HLA-DMB
Chagas disease	1/104	0.361940593415089	0.4233770041054731	0	0	2.2628212450028555	2.2996490843913855	GNA14
Amoebiasis	1/105	0.364698585699192	0.425034748774426	0	0	2.240950226244344	2.2604107705817387	GNA14
ERBB1 downstream pathway	1/106	0.36744479460287716	0.4266666662604838	0	0	2.2194957983193278	2.22211966490254	DUSP6
S phase	1/112	0.3836773699000366	0.4438895118916482	0	0	2.098887122416534	2.0106357656935216	MYC
Vascular smooth muscle contraction	1/116	0.3942696442683369	0.454485371756592	0	0	2.025473145780051	1.8851488269288186	KCNMA1
p53 activity regulation	1/118	0.39949810595436996	0.45884383908527276	0	0	1.9906485671191554	1.826512137437755	TTC5
Signaling by NOTCH	1/119	0.40209558442117593	0.459799930209585	0	0	1.973678963110668	1.79815070564473	MYC
Gene expression	5/968	0.4036599249037621	0.459799930209585	0	0	1.214760970731895	1.1020099253663385	MYC;ZSCAN32;ZNF514;CTGF;ZNF211
Interleukin-1 regulation of extracellular matrix	1/120	0.40468195750307323	0.459799930209585	0	0	1.9569945625308947	1.7704025881081817	DUSP6
Notch signaling pathway	1/121	0.4072572721420906	0.4610734116751526	0	0	1.9405882352941177	1.743250157166395	MYC
Pathways in cancer	2/325	0.40871255385274025	0.4610743045242657	0	0	1.444125018428424	1.2921210002394357	EGLN3;MYC
Rho GTPase cycle	1/123	0.4123749128496036	0.46355619635930617	0	0	1.908582449373192	1.6906650110301331	ARHGEF3
p75 neurotrophin receptor-mediated signaling	1/124	0.414917331782972	0.46476605715619124	0	0	1.8929698708751794	1.6652001246019699	ARHGEF3
Integration of energy metabolism	1/125	0.417448878008937	0.465955261721243	0	0	1.8776091081593929	1.6402665305040176	GNA14
Immune system	5/998	0.42942205101470265	0.47763786025144117	0	0	1.1761963373242326	0.9942564560160984	HLA-DMB;YES1;PTK2B;DUSP6;OASL
Mitotic G1-G1/S phases	1/135	0.44217635708929937	0.49010456362695065	0	0	1.7366110623353819	1.417155342018229	MYC
NGF signaling via TRKA from the plasma membrane	1/136	0.4445912947172885	0.49106425235324197	0	0	1.7236601307189543	1.397198656643996	DUSP6
Systemic lupus erythematosus	1/139	0.45177427951627525	0.4955447979469178	0	0	1.6859335038363172	1.3395965768152946	HLA-DMB
T cell receptor signaling pathway	1/139	0.45177427951627525	0.4955447979469178	0	0	1.6859335038363172	1.3395965768152946	NFATC3
EGF/EGFR signaling pathway	1/141	0.456511847532617	0.49901467471668826	0	0	1.6616806722689075	1.3029913230800254	PTK2B
Toll-like receptor signaling pathway regulation	1/142	0.45886543445060396	0.49986372069017676	0	0	1.6498122653316645	1.2852009220254814	FBXW5
Integrated breast cancer pathway	1/152	0.48185419151641307	0.5218882937700168	0	0	1.5397740553174912	1.1242101602899006	MYC
T cell receptor regulation of apoptosis	3/603	0.4823762462921606	0.5218882937700168	0	0	1.1634939759036145	0.8482230318564042	IGFBP5;MYC;PTK2B
Phagosome	1/154	0.48633474560244355	0.5243813413468524	0	0	1.5194925028835062	1.0953385017193233	HLA-DMB
Myometrial relaxation and contraction pathways	1/155	0.4885606405437286	0.5249956713639389	0	0	1.5095492742551566	1.0812775841638456	IGFBP5
Toll receptor cascades	1/159	0.49736928364314875	0.5326556179556695	0	0	1.4710349962769917	1.0274039446201135	DUSP6
Purine metabolism	1/164	0.5081694751227666	0.5423896417977003	0	0	1.425550342836521	0.9650124405266453	PAPSS2
Protein processing in the endoplasmic reticulum	1/166	0.5124250401417375	0.5450964353185598	0	0	1.4081283422459894	0.9414757949953488	EDEM2
Interferon signaling	1/168	0.5166442082540363	0.5477465351723395	0	0	1.3911236350827756	0.9186991984796388	OASL
Metapathway biotransformation	1/174	0.529086394818438	0.5590679571914828	0	0	1.3424685481128869	0.8546202343921173	CYP27B1
Chemokine signaling pathway	1/189	0.5588238918519959	0.5885288163358229	0	0	1.2344180225281602	0.7183336427853815	PTK2B
Protein metabolism	2/442	0.5698239248388295	0.5965216226639563	0	0	1.0537878787878787	0.5926796717461743	FBXW5;EDEM2
Amino acid metabolism	1/195	0.5701922256562638	0.5965216226639563	0	0	1.1958762886597938	0.6718214586948186	GOT2
Post-translational protein modification	1/196	0.572058590819693	0.5965216226639563	0	0	1.1896832579185521	0.6644545901577418	EDEM2
Jak-STAT signaling pathway	1/199	0.5776097586829732	0.600335388532795	0	0	1.1714795008912655	0.6429744858131342	MYC
Platelet activation, signaling and aggregation	1/205	0.5884994497040088	0.6095148181435577	0	0	1.1366782006920415	0.6026432384058288	GNA14
Gastrin-CREB signaling pathway via PKC and MAPK	1/206	0.5902872213566946	0.6095148181435577	0	0	1.1310760401721665	0.5962422608090345	GNA14
Carbohydrate metabolism	1/235	0.6389216689866785	0.65759145801551	0	0	0.9894419306184012	0.4432436814582167	GOT2
Signal transduction	4/1020	0.6449821515645301	0.661680718595327	0	0	0.9073362780871903	0.39789656846345267	GNA14;MYC;ARHGEF3;DUSP6
Apoptosis	1/242	0.6497784160636703	0.6644508319102692	0	0	0.9603612399316573	0.4140346568303555	MYC
Neuronal system	1/283	0.7071863921103074	0.7208298594822105	0	0	0.8190237797246558	0.28375980574847454	KCNMA1
Adaptive immune system	2/606	0.7391315653350565	0.7509766224718363	0	0	0.761195206559445	0.2300935864030953	HLA-DMB;YES1
Innate immune system	1/319	0.7498572763584855	0.7594401169509262	0	0	0.7249722530521643	0.20869949426320789	DUSP6
Axon guidance	1/325	0.7563451118104483	0.7635713389933507	0	0	0.7113289760348583	0.19864395854013847	NFATC3
Disease	2/674	0.7909380344312767	0.7959598632213166	0	0	0.6817602040816326	0.15989707434655678	IGFBP5;MYC
Cell cycle	1/453	0.861174433302775	0.8638996688512015	0	0	0.5065590838105154	0.07570940948110061	MYC
Signaling by GPCR	2/977	0.9274440530207669	0.9274440530207669	0	0	0.4624908424908425	0.03483610824303039	GNA14;ARHGEF3
